Biomedical Research Institute, Hasselt University, Hasselt, Belgium.
Amsterdam UMC, Vrije Universiteit Amsterdam, Physiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Cell Physiol Biochem. 2020 Aug 29;54(5):809-824. doi: 10.33594/000000271.
BACKGROUND/AIMS: High-molecular-weight advanced glycation end-products (HMW-AGEs) are abundantly present in our Western diet. There is growing evidence reporting that HMW-AGEs contribute to the development of cardiovascular dysfunction in vivo, next to the well-known low-molecular-weight AGEs. The goal of our study is to assess the ultrastructure and function of cardiomyocytes after chronic exposure to HMW-AGEs. A better understanding of underlying mechanisms is essential to create new opportunities for further research on the specific role of HMW-AGEs in the development and progression of cardiovascular diseases.
Adult male rats were randomly assigned to daily intraperitoneal injection for six weeks with either HMW-AGEs (20 mg/kg/day) or a control solution. Hemodynamic measurements were performed at sacrifice. Single cardiomyocytes from the left ventricle were obtained by enzymatic dissociation through retrograde perfusion of the aorta. Unloaded cell shortening, time to peak and time to 50% relaxation were measured during field stimulation and normalized to diastolic length. L-type Ca current density (I) and steady-state inactivation of I were measured during whole-cell ruptured patch clamp. Myofilament functional properties were measured in membrane-permeabilized cardiomyocytes. Ultrastructural examination of cardiac tissue was performed using electron microscopy.
RESULTS: Rats injected with HMW-AGEs displayed in vivo cardiac dysfunction, characterized by significant changes in left ventricular peak rate pressure rise and decline accompanied with an increased heart mass. Single cardiomyocytes isolated from the left ventricle revealed concentric hypertrophy, indicated by the increase in cellular width. Unloaded fractional cell shortening was significantly reduced in cells derived from the HMW-AGEs group and was associated with slower kinetics. Peak L-type Ca current density was significantly decreased in the HMW-AGEs group. L-type Ca channel availability was significantly shifted towards more negative potentials after HMW-AGEs injection. The impact of HMW-AGEs on myofilament function was measured in membrane-permeabilized cardiomyocytes showing a reduction in passive force, maximal Ca activated force and rate of force development. Ultrastructural examination of cardiac tissue demonstrated adverse structural remodeling in HMW-AGEs group characterized by a disruption of the cyto-architecture, a decreased mitochondrial density and altered mitochondrial function.
Our data indicate that HMW-AGEs induce structural and functional cellular remodeling via a different working mechanism as the well-known LMW-AGEs. Results of our research open the door for new strategies targeting HMW-AGEs to improve cardiac outcome.
背景/目的:高分子量晚期糖基化终产物(HMW-AGEs)在我们的西方饮食中大量存在。越来越多的证据表明,HMW-AGEs 除了众所周知的低分子量 AGEs 外,还会导致体内心血管功能障碍的发展。我们研究的目的是评估慢性暴露于 HMW-AGEs 后心肌细胞的超微结构和功能。深入了解潜在机制对于创造新的机会来进一步研究 HMW-AGEs 在心血管疾病发展和进展中的特定作用至关重要。
成年雄性大鼠随机分为每天腹腔注射 HMW-AGEs(20mg/kg/天)或对照溶液 6 周。在牺牲时进行血流动力学测量。通过主动脉逆行灌注酶解获得左心室的单个心肌细胞。在场刺激期间测量未加载细胞缩短、峰值时间和 50%松弛时间,并归一化为舒张长度。在全细胞膜片钳破裂贴片期间测量 L 型钙电流密度(I)和 I 的稳态失活。在膜通透性心肌细胞中测量肌丝功能特性。使用电子显微镜对心脏组织进行超微结构检查。
注射 HMW-AGEs 的大鼠表现出体内心脏功能障碍,其特征在于左心室峰值压力上升和下降的显著变化,同时伴有心脏质量增加。从左心室分离的单个心肌细胞显示出同心性肥大,表现为细胞宽度增加。来自 HMW-AGEs 组的细胞的未加载分数细胞缩短明显减少,并且动力学较慢。在 HMW-AGEs 组中,L 型钙电流密度显著降低。L 型钙通道可用性在 HMW-AGEs 注射后明显向更负的电位移动。在膜通透性心肌细胞中测量 HMW-AGEs 对肌丝功能的影响,显示被动力、最大 Ca 激活力和力发展速率降低。心脏组织的超微结构检查显示 HMW-AGEs 组存在不良的结构重塑,其特征是细胞结构破坏、线粒体密度降低和线粒体功能改变。
我们的数据表明,HMW-AGEs 通过与众所周知的 LMW-AGEs 不同的工作机制诱导结构和功能细胞重塑。我们研究的结果为靶向 HMW-AGEs 以改善心脏结局的新策略开辟了道路。